The FDA is kicking off May with three target action dates and three advisory committee meetings, including one for a high-profile investigational gene therapy.
Tag Archive for: MydCombi
Today Eyenovia announced that the FDA had approved its pupil-dilating spray to be used with the company’s proprietary drug delivery device during eye examinations.